The Canadian HBV Network is a collaborative organization of healthcare professionals and researchers from across Canada with an interest in advancing excellence in Hepatitis B patient care, research and education.
WE are proudly affiliated with the following organizations:
The Canadian Association for the Study of the Liver (CASL) is a multidisciplinary group of scientists and healthcare providers whose expertise focuses on the liver, and provides national leadership in all aspects of research, education and patient care as they pertain to the liver.
Liver Canada (formerly The Canadian Liver Foundation) aims to promote liver health, increase public understanding and awareness of liver diseases, and provide support to those affected.
ICE-HBV is a global group working to enhance HBV prevention, care, treatment and cure.
They aim to fast-track the discovery of a safe, effective, affordable and scalable cure to benefit all people living with CHB, including children and people living with HCV, HDV and HIV co-infection.
To achieve this, they provide an international research-driven forum, which coordinates, promotes and establishes public-private collaborative partnerships to accelerate the discovery of a CHB cure.
The Canadian Network on Hepatitis C (CanHepC) is a national collaborative research and training network dedicated to the advancement of hepatitis C virus research. CanHepC brings together over 100 members including researchers, student trainees and knowledge-users from across Canada, as well as international partners. Their overarching goal is to improve health outcomes for people living with hepatitis C at all stages of the cascade of care, closing the gap between knowledge and practices while training and building capacity in research.
The Canadian MASLD Network is a collaborative organization of health care professionals from across Canada with a primary interest in enhancing understanding, care of, education, and research in persons with MASLD* (formerly NAFLD) by focusing on epidemiology, diagnostics, therapy and prevention.
*Metabolic Dysfunction-Associated Steatotic Liver Disease
